|
Female (%)
|
79.8%
|
|
Age (years)
|
59.9 ± 12.7
|
|
Disease duration (years)
|
11.5 ± 10.2
|
|
Rheumatoid factor positive(%)
|
59%
|
|
C-reactive protein (mg/dl)
|
2.1
|
|
Erythrocyte sedimentation rate (mm/hour)
|
25.9 ± 21.9
|
|
Swollen-joint count 28
|
2.1 ± 3.0
|
|
Tender-joint count 28
|
2.1 ± 3.8
|
|
Visual analogue scale pain (mm)
|
28.0 ± 22.4
|
|
Patient global assessment of disease activity (mm)
|
30.0 ± 23.3
|
|
Evaluator global assessment of disease activity (mm)
|
11.0 ± 13.7
|
|
Clinical disease activity index
|
8.3 ± 7.3
|
|
Simplified disease activity index
|
9.1 ± 7.7
|
|
Disease activity score 28
|
3.2 ± 1.2
|
|
Health-assessment questionnaire
|
0.81 ± 0.76
|
|
Euro QolL5D
|
0.77 ± 0.19
|
|
Physical component score SF-36
|
37.6 ± 11.3
|
|
Mental component score SF-36
|
48.0 ± 12.0
|
|
Patients currently employed (%)
|
26.5%
|
|
Activity impairment due to problem (%)
|
35.9 ± 26.7
|
|
Work time missed due to RA (%)
|
7.7 ± 24.5
|
|
Impairment while working due to problem (%)
|
27.8 ± 26.8
|
|
Overall work impairment due to RA (%)
|
2.7 ± 10.5
|
